Yeom Jong Hun, Park Ji Sun, Oh Ock-Hee, Shin Hyun Taek, Oh Jung Mi
College of Medicine, Han Yang University, Seoul, Korea.
Ann Pharmacother. 2005 Nov;39(11):1918-23. doi: 10.1345/aph.1E674. Epub 2005 Oct 11.
In Korea, the drug use process has changed significantly since the new pharmacy law was implemented in 2000, separating the prescribing and dispensing functions between physicians and pharmacists and mandating prospective drug use review (DUR) practice by pharmacists immediately before dispensing medications. However, a high prevalence of inappropriate prescribing has been suspected by the public, pharmacists, and health insurance managers, possibly due to suboptimal DUR practice by pharmacists.
To assess overall patterns of drug usage and potential problems of inappropriate use in outpatient settings by analyzing prescription data that were electronically submitted to the national health insurance manager with a computerized DUR system and develop a computerized adjudication system model for drug claims.
The national prescription drug claims data that were submitted electronically by pharmacies located in the northern part of Korea during 15 days in 2002 were retrospectively screened against the predetermined DUR standards of the selected criteria on drug dosage, duration of therapy, and drug interaction using the DUR screening system. The results of all the DUR conflicts were further validated manually by an expert panel and statistically analyzed to determine drug use patterns.
Of 31,994,260 drugs prescribed, 3,325,760 (10.4%) items showed a conflict with at least one of the DUR standards. The average number of drugs prescribed on each prescription was 4.07, and even more troubling was the high incidence of under-dosing, over-dosing, and contraindicated drug prescribing.
It is evident that inappropriate drug prescribing is very common in Korea; thus, a great deal of attention is urgently needed in the country with respect to proper prescribing and supportive interventions.
在韩国,自2000年新药房法实施以来,用药流程发生了显著变化,该法律将医生和药剂师的处方和配药职能分开,并要求药剂师在配药前立即进行前瞻性用药审查(DUR)。然而,公众、药剂师和医疗保险管理人员怀疑不适当处方的发生率很高,这可能是由于药剂师的DUR实践未达到最佳效果。
通过分析使用计算机化DUR系统电子提交给国家医疗保险管理人员的处方数据,评估门诊环境中的药物使用总体模式和不当使用的潜在问题,并开发药物索赔的计算机化裁决系统模型。
使用DUR筛查系统,根据选定的药物剂量、治疗持续时间和药物相互作用标准的预定DUR标准,对2002年韩国北部药房在15天内电子提交的国家处方药索赔数据进行回顾性筛查。所有DUR冲突的结果由专家小组进一步人工验证,并进行统计分析以确定药物使用模式。
在开出的31994260种药物中,3325760种(10.4%)与至少一项DUR标准存在冲突。每张处方开出的药物平均数量为4.07种,更令人担忧的是,用药不足、用药过量和禁忌药物处方的发生率很高。
显然,韩国不适当的药物处方非常普遍;因此,该国迫切需要在正确处方和支持性干预方面给予高度关注。